Blood Sugar Monitoring

The Advanced Blood Sugar Monitoring - Basic panel is designed to provide fundamental insights into an individual's glucose metabolism and overall blood sugar control. This panel includes two essential tests: Glucose and Hemoglobin A1c, making it an invaluable tool for initial diabetes screening and monitoring.

The Advanced Blood Sugar Monitoring - Basic Plus panel offers a more detailed look into blood sugar regulation and potential autoimmune aspects of diabetes. It includes the 3 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, and 3 Specimens Insulin Response to Glucose, providing a comprehensive evaluation of glucose metabolism and insulin function.

The Advanced Blood Sugar Monitoring - Advanced panel provides an in-depth analysis of blood sugar regulation, insulin function, and potential autoimmune aspects of diabetes. This comprehensive panel includes Adiponectin, a 4 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, and a 4 Specimens Insulin Response to Glucose test.

The Advanced Blood Sugar Monitoring - Comprehensive panel is the most extensive assessment in the series, designed to provide a detailed analysis of glucose metabolism, insulin sensitivity, and autoimmune diabetes indicators. It includes Adiponectin, a 5 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, IA-2 Antibody, a 4 Specimens Insulin Response to Glucose, and Proinsulin tests.

The Cardio IQ™ Insulin Resistance Panel with Score Test measures markers of insulin resistance to evaluate glucose control, lipid metabolism, and cardiometabolic health. The score offers insight into type 2 diabetes risk, cardiovascular disease, and endocrine balance. This test supports monitoring of metabolic function, energy regulation, and systemic conditions tied to insulin resistance.

The Cardio IQ™ Diabetes and ASCVD Risk Panel with Scores measures advanced cardiovascular and metabolic markers to evaluate risk for atherosclerotic cardiovascular disease and type 2 diabetes. This panel includes lipid analysis, glucose-related biomarkers, and inflammation indicators, helping assess cardiometabolic health. Results provide clinicians with detailed scoring to identify patterns that may influence prevention and long-term disease management.

The Cardio IQ™ Diabetes Risk Panel with Score combines advanced biomarker analysis to evaluate insulin resistance, lipid metabolism, and glycemic control. This panel generates a diabetes risk score that helps identify individuals at increased risk for type 2 diabetes and related cardiometabolic complications. It provides insight into metabolic health, supporting early intervention, lifestyle planning, and long-term disease management.

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

The Diabetes Risk Panel with Score combines multiple biomarkers to assess risk of developing type 2 diabetes and related metabolic conditions. By evaluating glucose control, insulin resistance, lipid levels, and inflammation markers, this panel provides a personalized score that reflects overall metabolic health. Clinicians use it to help identify individuals at increased risk, support early intervention, and monitor long-term health.

The Urinalysis Complete Test evaluates urine for physical, chemical, and microscopic properties to assess kidney health, urinary tract infections, diabetes, and metabolic disorders. It measures appearance, concentration, pH, protein, glucose, ketones, blood, bilirubin, nitrites, leukocyte esterase, and microscopic cells or crystals. Doctors use this test in routine exams, to diagnose urinary symptoms, and to monitor chronic kidney or metabolic disease.

The Hemoglobin A1c (HbA1c) test measures the average blood glucose level over the past two to three months. It provides valuable information about long-term blood sugar control in individuals with diabetes.

The Hemoglobin A1c (HbA1c) Test measures average blood glucose over 2–3 months by detecting sugar attached to hemoglobin in red blood cells. It is used to diagnose diabetes, identify prediabetes, and monitor long-term blood sugar control. Doctors rely on the HbA1c test to evaluate treatment effectiveness, guide adjustments, and assess risk for complications, making it essential for diabetes care and metabolic health screening.

 The Hemoglobin A1c and Glucose panel is a combination of two essential blood tests that provide valuable information about an individual's blood sugar levels over both short and extended periods. This panel helps healthcare professionals assess how well a person's blood sugar is being managed and can indicate the risk or presence of diabetes.

The Hemoglobin A1c with eAG Test measures average blood sugar levels over the past 2–3 months and provides an estimated average glucose (eAG) value for easier understanding. It is widely used to screen, diagnose, and monitor diabetes and prediabetes. Doctors use this test to evaluate long-term glucose control, adjust treatment, and reduce the risk of complications such as neuropathy, kidney disease, and heart problems linked to poor blood sugar management.

The Proinsulin Test evaluates the concentration of proinsulin in blood to assess pancreatic function and glucose metabolism. Abnormal results may suggest beta-cell dysfunction, insulin resistance, or progression toward type 2 diabetes. This test provides insight into endocrine health, metabolic balance, and systemic conditions tied to abnormal hormone regulation and impaired glucose control.

The Glucose Test measures blood sugar levels to evaluate energy metabolism and screen for diabetes or prediabetes. Abnormal glucose may indicate hyperglycemia, hypoglycemia, or metabolic disorders. Doctors use this test during routine exams, to investigate symptoms like fatigue, excessive thirst, or frequent urination, and to monitor treatment for diabetes. It provides essential insight into how the body regulates blood sugar and overall metabolic health.

The Adiponectin Test measures adiponectin, a hormone made by fat cells that helps regulate glucose levels and fatty acid breakdown. Low adiponectin is linked to insulin resistance, type 2 diabetes, obesity, and cardiovascular disease. Doctors use this test to evaluate metabolic health, assess risk for diabetes or heart disease, and monitor patients with weight-related or endocrine disorders. Results help guide prevention and treatment strategies.

The Basic Metabolic Panel (BMP) Test measures eight markers, including glucose, calcium, sodium, potassium, chloride, carbon dioxide, BUN, and creatinine, to evaluate kidney function, blood sugar, and electrolyte balance. Doctors use this panel to detect diabetes, dehydration, and kidney disease, or to monitor treatment. It is commonly ordered in routine exams, emergency care, or pre-surgical testing to assess overall metabolic and organ health.

The Basic Metabolic Panel Plasma Test measures key blood chemistries including glucose, calcium, sodium, potassium, chloride, carbon dioxide, blood urea nitrogen, and creatinine. These markers provide insight into kidney function, electrolyte balance, and metabolic health. Clinicians often use the results to assess conditions such as dehydration, renal disease, or metabolic disorders and to monitor overall systemic health.

The Beta-Hydroxybutyrate Test measures levels of beta-hydroxybutyrate, the primary ketone body in the blood, to assess ketosis and detect ketoacidosis. Elevated BHB is commonly associated with diabetic ketoacidosis, prolonged fasting, alcohol-related ketosis, or metabolic disorders. This test helps monitor ketone production, evaluate metabolic health, and distinguish between nutritional ketosis and pathological states.

The C-Peptide Test measures C-peptide levels in blood to assess insulin production and pancreatic function. Low levels may indicate type 1 diabetes or reduced insulin production, while high levels may suggest type 2 diabetes, insulin resistance, or insulinoma. Doctors use this test to differentiate diabetes types, monitor treatment, and evaluate unexplained hypoglycemia. It provides key insight into endocrine, pancreatic, and metabolic health.

The C-Peptide Response to Glucose Test with 2 specimens evaluates pancreatic beta cell activity and insulin secretion during glucose intake. By measuring changes in C-peptide levels at two time points, it helps assess insulin production, glucose regulation, and potential insulin resistance or diabetes-related disorders. This test offers insight into metabolic health and endocrine function.

The C-Peptide Response to Glucose Test with 3 specimens measures pancreatic beta cell function and insulin secretion at multiple time points. Tracking C-peptide levels across three collections provides insight into insulin production, glucose regulation, and metabolic health, supporting evaluation of diabetes risk, hypoglycemia, and overall endocrine function.